Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ralph Lauren | RL | Nov 25, 2024 | 220.00 | +3.70 |
Ramaco Resources A | METC | Nov 25, 2024 | 12.44 | -0.96 |
Ramaco Resources B | METCB | Nov 25, 2024 | 10.36 | +2.37 |
Rambus | RMBS | Nov 25, 2024 | 56.89 | +1.66 |
Rand Capital | RAND | Nov 25, 2024 | 16.49 | +0.95 |
Range Resources | RRC | Nov 25, 2024 | 35.83 | +0.31 |
Ranger Energy Services A | RNGR | Nov 25, 2024 | 16.50 | -1.96 |
Rani Therapeutics A | RANI | Nov 25, 2024 | 2.08 | 0.00 |
Ranpak A | PACK | Nov 25, 2024 | 7.83 | +4.82 |
Rapid Micro Biosystems A | RPID | Nov 25, 2024 | 1.10 | -4.35 |
Rapid7 | RPD | Nov 25, 2024 | 42.74 | -0.28 |
Rapport Therapeutics | RAPP | Nov 25, 2024 | 22.33 | -3.29 |
RAPT Therapeutics | RAPT | Nov 25, 2024 | 1.12 | +3.70 |
Rare Earth/Str Metals ETF Market Vectors | REMX | Nov 25, 2024 | 46.36 | +0.56 |
Rave Restaurant Group | RAVE | Nov 25, 2024 | 2.81 | -2.77 |
Raymond James Financial | RJF | Nov 25, 2024 | 167.05 | +1.13 |
Raymond James Financial B | RJF-B | Nov 25, 2024 | 25.27 | +0.20 |
Rayonier Advanced Materials | RYAM | Nov 25, 2024 | 8.91 | +0.23 |
Rayonier REIT | RYN | Nov 25, 2024 | 31.62 | +1.84 |
Raytech Holding | RAY | Nov 25, 2024 | 1.36 | -8.72 |
RB Global | RBA | Nov 25, 2024 | 98.50 | +0.71 |
RBB Bancorp | RBB | Nov 25, 2024 | 24.63 | +1.03 |
RBC Bearings | RBC | Nov 25, 2024 | 338.78 | +0.58 |
RCI Hospitality | RICK | Nov 25, 2024 | 53.21 | +2.96 |
RCM Technologies | RCMT | Nov 25, 2024 | 23.28 | +8.18 |
RDE | RSTN | Nov 25, 2024 | 3.25 | 0.00 |
RE/MAX A | RMAX | Nov 25, 2024 | 14.04 | +6.12 |
Reading International A | RDI | Nov 25, 2024 | 1.45 | +0.69 |
Reading International B | RDIB | Nov 25, 2024 | 6.70 | +4.54 |
Ready Capital | RC | Nov 25, 2024 | 7.37 | -0.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.